1. Home
  2. SRRK vs ACT Comparison

SRRK vs ACT Comparison

Compare SRRK & ACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scholar Rock Holding Corporation

SRRK

Scholar Rock Holding Corporation

HOLD

Current Price

$49.84

Market Cap

5.6B

Sector

Health Care

ML Signal

HOLD

Logo Enact Holdings Inc.

ACT

Enact Holdings Inc.

HOLD

Current Price

$42.05

Market Cap

5.8B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRRK
ACT
Founded
2012
1981
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
5.8B
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
SRRK
ACT
Price
$49.84
$42.05
Analyst Decision
Strong Buy
Hold
Analyst Count
12
3
Target Price
$55.64
$42.67
AVG Volume (30 Days)
1.7M
240.4K
Earning Date
05-13-2026
05-05-2026
Dividend Yield
N/A
1.99%
EPS Growth
N/A
3.43
EPS
N/A
4.52
Revenue
N/A
$1,235,827,000.00
Revenue This Year
N/A
$4.22
Revenue Next Year
$544.77
$2.33
P/E Ratio
N/A
$9.32
Revenue Growth
N/A
2.83
52 Week Low
$27.07
$33.94
52 Week High
$51.63
$44.80

Technical Indicators

Market Signals
Indicator
SRRK
ACT
Relative Strength Index (RSI) 59.40 57.71
Support Level $41.07 $39.43
Resistance Level N/A $42.80
Average True Range (ATR) 2.21 0.82
MACD 0.51 0.20
Stochastic Oscillator 82.19 70.99

Price Performance

Historical Comparison
SRRK
ACT

About SRRK Scholar Rock Holding Corporation

Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.

About ACT Enact Holdings Inc.

Enact Holdings Inc is a private mortgage insurance company serving the United States housing finance market. The company operates in a single reportable segment namely Mortgage Insurance The principal mortgage insurance customers are originators of residential mortgage loans that determines the mortgage insurer or insurers to be used for the placement of mortgage insurance written on loans originated. The company is engaged in writing and assuming residential mortgage guaranty insurance.

Share on Social Networks: